# Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)

> **NCT01230580** · PHASE4 · UNKNOWN · sponsor: **Medical Research Council** · enrollment: 587 (actual)

## Conditions studied

- HIV Infection
- Acquired Immunodeficiency Syndrome

## Interventions

- **DRUG:** Protease Inhibitor
- **DRUG:** Standard-of-care Antiretroviral therapy

## Key facts

- **NCT ID:** NCT01230580
- **Lead sponsor:** Medical Research Council
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 587 (ACTUAL)
- **Last updated:** 2012-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01230580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01230580, "Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01230580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*